UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act 1934
Date of Report (Date of earliest event reported): April 2, 2018
Merion, Inc. |
(Exact name of registrant as specified in its charter) |
Nevada | | 333-173681 | | 45-2898504 |
(State or Other Jurisdiction of Incorporation) | | (Commission File Number) | | (I.R.S. Employer Identification No.) |
9550 Flair Dr, Suite 302, El Monte CA | | 91731 |
(Address of Principal Executive Offices) | | (Zip Code) |
Registrant’s telephone number, including areas code: (626) 448-3737
None
(Former Name or Former Address, is Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A2. below):
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 1.01 Entry into a Material Definitive Agreement
On April 2, 2018, Merion, Inc. (the “Company”), entered into a series of Securities Purchase Agreements (collectively, the “Purchase Agreements”) with the purchasers described therein (collectively, the “Purchasers”), pursuant to which the Company agreed to sell to the Purchasers in a series of private placements an aggregate of 192,782 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a purchase price of $0.90 per Share for an aggregate offering price of approximately $173,500 (the “Private Placement”). The Private Placement will be completed pursuant to the exemption from registration provided by Regulation S promulgated under the Securities Act of 1933, as amended.
The representations, warranties and covenants contained in the Purchase Agreements were made solely for the benefit of the parties to the respective Purchase Agreements. In addition, such representations, warranties and covenants (i) are intended as a way of allocating the risk between the parties to the Purchase Agreements and not as statements of fact, and (ii) may apply standards of materiality in a way that is different from what may be viewed as material by shareholders of, or other investors in, the Company. Accordingly, the Purchase Agreements are filed with this report only to provide investors with information regarding the terms of transaction, and not to provide investors with any other factual information regarding the Company. Shareholders should not rely on the representations, warranties and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of the Company. Moreover, information concerning the subject matter of the representations and warranties may change after the date of the Purchase Agreements, which subsequent information may or may not be fully reflected in public disclosures.
The Purchase Agreements are filed as Exhibits 10.1. 10.2, 10.3, 10.4, 10.5 and 10.6 to this Current Report on Form 8-K. The foregoing summary of the terms of the Purchase Agreements is subject to, and qualified in its entirety by, the Purchase Agreements, which are incorporated herein by reference.
Item 3.02 Unregistered Sales of Equity Securities
Please see the disclosure set forth under Item 1.01, which is incorporated by reference into this Item 3.02.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
Exhibit No. | | Exhibit Title or Description |
10.1 | | Securities Purchase Agreement by and between Merion, Inc. and Lie Zhi Cui, dated April 2, 2018. |
10.2 | | Securities Purchase Agreement by and between Merion, Inc. and Sheng Wen Guan, dated April 2, 2018. |
10.3 | | Securities Purchase Agreement by and between Merion, Inc. and Chaoxia Zhang, dated April 2, 2018. |
10.4 | | Securities Purchase Agreement by and between Merion, Inc. and Jin Hua Wang, dated April 2, 2018. |
10.5 | | Securities Purchase Agreement by and between Merion, Inc. and Zi Qing Peng, dated April 2, 2018. |
10.6 | | Securities Purchase Agreement by and between Merion, Inc. and Qiong Fen Liu, dated April 2, 2018. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Merion, Inc. |
| | | |
Dated: April 3, 2018 | By: | /s/ Ding Hua Wang | |
| | Ding Hua Wang | |
| | President, Chief Executive Officer and Chief Financial Officer | |
